Article summary
NEW YORK, August 06, 2026--Definium Therapeutics, Inc. ("Definium" or the "Company") (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics…
Continue to the original publication for the complete article.